Scientific Library
New - you know CRISPR, now it's Prime Editing
This month, a new leap forward in gene editing has been published in Nature under the title 'Search-and-replace genome editing without double-strand breaks or donor DNA'. DOI: 10.1038/s41586-019-1711-4.
How can CRISPR/Cas9 be used to edit genomes?
Genes are key components of our lives. With many other factors, they contribute to shaping us, making people and any other living organism what they are. Genomes, whether human or not, are able
Accelerate your mRNA-based proof-of-concepts studies with Tebubio
Watch this on-demand webinar to learn how Tebubio's Contract Research Service laboratory and experts can help you overcome the key challenges in developing innovative mRNA-based therapies.
Enhance Your Therapeutic mRNA Research Projects with Modified NTPs
How Modified NTPs are Revolutionising mRNA Vaccine Technology
In recent years, the spotlight on mRNA (messenger RNA) technology has intensified, largely due to its pivotal role
Optimising mRNA for Therapeutics: The Synergy of CleanCap Technology and Minimal UTRs
mRNA and UTRs: Unlocking New Frontiers in Therapeutic Innovation
Over the past five years, there has been an explosive surge in scientific interest surrounding messenger RNA (mRNA),
Revolutionising mRNA Production: When Simplicity Meets Efficiency
mRNA-Based Therapeutics: Pioneering the Future of Medicine
Over the past few years, mRNA-based therapeutics have emerged as a promising approach to treat various diseases, including
Unlocking the Next Frontier in Immuno-Oncology: Powering T and NK Cell Therapies with Nanotein’s Innovative Platforms
Powering T and NK Cell Therapies with Nanotein’s Innovative Platforms
In the ever-evolving field of immuno-oncology, the race to develop the most effective cell-based therapies has never been
The Full TriLink Catalog Expertly Delivered by Tebubio
Looking for high-quality mRNA, nucleotides, and custom oligonucleotides?Tebubio delivers the complete TriLink catalogue, giving researchers easy access
[Immuno-Oncology Newsletter - Edition 6] Tackling Cancer with Gene & Cell Therapy: The Next Frontier
This exclusive monthly publication brings you cutting-edge advancements and premium solutions from top suppliers in the field. Carefully curated to keep you at the forefront
[Tebubio Newsletter - Edition 1] Everything You Need, in One Place
Stay ahead in your research with your monthly Tebubio newsletter—your go-to source for innovative reagents, expert services, and insightful articles. Curated to bring you the most relevant products, services
Development and Imaging Validation of Fluorescent Lipid Nanoparticles for RNA Delivery Applicable to Personalized In Vitro Oncology Models
Discover how Tebubio's innovative LNP platform enables real-time tracking of RNA delivery in oncology models. Explore our latest findings and applications for personalized medicine.
[Immuno-Oncology Newsletter - Edition 7] From RNA to TME: Tools & Insights to Accelerate Immuno-Oncology Research
This exclusive monthly publication #7 brings you cutting-edge advancements and premium solutions from top suppliers in the field. Carefully curated to keep you at the